New Drug To Fight Against Localized High-Risk Prostate Tumors
Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized. The study, conducted by researchers at Dana-Farber Cancer Institute in collaboration with other research centers, will be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... (Source: Health News from Medical News Today)

Hospitals and Insurers Join to Cut Health Care Costs
Insurers, hospitals and doctors say they are forming partnerships and creating programs to find ways to slow the growth in the nation’s $2.7 trillion health care bill. (Source: NYT Health)